Skip to main content
AmigoFish

PK in patients with impaired renal function (Ep. 12)

From Clinical Pharmacology Podcast with Nathan Teuscher · · 14 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

In today’s episode I discuss the evaluation of pharmacokinetics in patients with impaired renal function. I include information from both the US FDA and EMA guidance documents linked below. I discuss the determination of when a dedicated renal impairment study is needed, characteristics of the study design and how to analyze and interpret the results.

Links discussed in the show:

• FDA guidance (https://go.teuschersolutions.com/fda-renal) on PK in patients with impaired renal function

• EMA guidance (https://go.teuschersolutions.com/ema-renal) on Evaluation of PK in patients with decreased renal function

• You can connect with me on LinkedIn (https://go.teuschersolutions.com/linkedin) and send me a message.

• Send me a message (https://go.teuschersolutions.com/contact)

• Sign up for my newsletter (https://go.teuschersolutions.com/newsletter)

Copyright Teuscher Solutions LLC

All Rights Reserved

Back to Clinical Pharmacology Podcast with Nathan Teuscher · Report a problem